Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 22, 2019
Berberine reduces endothelial injury and arterial stiffness in spontaneously hypertensive ratsGaoxing Zhang, Xiufang Lin, Yijia Shao, et al.
Mediators of Inflammation|August 16, 2021
The Emerging Roles of CCN3 Protein in Immune-Related DiseasesLinan Peng, Yingying Wei, Yijia Shao, et al.
Small Methods|May 6, 2024
Lithium-Ion Conductive Coatings for Nickel-Rich Cathodes for Lithium-Ion BatteriesYijia Shao, Jia Xu, Amardeep Amardeep, et al.
Annals of Translational Medicine|January 6, 2022
Trimethylamine-N-oxide-stimulated hepatocyte-derived exosomes promote inflammation and endothelial dysfunction through nuclear factor-kappa B signalingXiang Liu, Yijia Shao, Jiazichao Tu, et al.
Food Science & Nutrition|January 17, 2022
Egg consumption improves vascular and gut microbiota function without increasing inflammatory, metabolic, and oxidative stress markersXiang Liu, Yijia Shao, Jiapan Sun, et al.
Cardiovascular Therapeutics|June 26, 2025
Trimethylamine-N-Oxide Impedes Late Endothelial Progenitor Cell-Mediated Revascularization by Triggering Mitochondrial Apoptosis via Suppression of MnSODYijia Shao, Jiapan Sun, Xiang Liu, et al.
ACS Applied Materials & Interfaces|December 19, 2024
Carbon Dioxide Evolution in Aqueous Zinc Metal BatteriesZhenrui Wu, Yijia Shao, Evan J Hansen, et al.
Molecules (Basel, Switzerland)|April 12, 2022
Significant Enhancement of the Capacity and Cycling Stability of Lithium-Rich Manganese-Based Layered Cathode Materials via Molybdenum Surface ModificationYijia Shao, Zhiyuan Lu, Luoqian Li, et al.
Cardiology Research and Practice|May 27, 2020
Smoking-Induced Inhibition of Number and Activity of Endothelial Progenitor Cells and Nitric Oxide in Males Were Reversed by Estradiol in Premenopausal FemalesYijia Shao, Liang Luo, Zi Ren, et al.
Heliyon|February 1, 2024
An epidermal growth factor receptor-mutated lung adenocarcinoma patient with brain lesions resisted to osimertinib monotherapy but achieved more than 4 years of survival in osimertinib plus bevacizumab metronomic treatmentJie Liu, Xiao Han, Xiufeng Hu, et al.
Pageof 5